Data presented by Yang et al. [23] confirmed the efficacy of simultaneous use of PI3 K/AKT/mTOR signaling pathway inhibitors in reducing cell proliferation, survival, and invasion in human colon cancer. Here, MTOR is linked to colonic neoplasm.